We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.


Allen S. Ho, MD

Director, Head and Neck Cancer Program

Co-Director, Thyroid Cancer Program

8635 W. Third St.
West Medical Office Tower, Suite 590W
Los Angeles, CA 90048





Parking Instructions:

Parking entrance is located on George Burns Road between Third St. and Alden Drive.

Allen S. Ho, MD

Director, Head and Neck Cancer Program

Co-Director, Thyroid Cancer Program

  • Otolaryngology

HPV (Human Papillomavirus)

Head and Neck Cancers

Head and Neck Surgery / Surgeries

Head and Neck Tumors

Laryngeal Cancer

Oral Surgery

Oropharyngeal Cancers (Tonsil, Tongue Base)

Parathyroid Surgery / Surgeries

Salivary Gland Disorders

Salivary Gland Tumors

Sinus Cancers

Sinus Surgery / Surgeries

Skin Cancer Surgery / Surgeries

Skull Base Surgery / Surgeries

Thyroid Cancers

Thyroid Surgery / Surgeries

The research interests of Allen Ho, MD, lie in head and neck cancer genomics, HPV+ oropharyngeal cancer pathogenesis, transoral robotic surgery, and thyroid cancer active surveillance.

  • Undergraduate: Harvard University, 2000
  • Fellowship: National Institutes of Health, 2004
  • Medical School: UCLA, 2006
  • Residency: Stanford University School of Medicine, 2011
  • Fellowship: Memorial Sloan Kettering Cancer Center, 2013
  • Super Doctors Rising Stars, 2015
  • Young Investigator Award, American Head and Neck Society
  • National Institutes of Health Ruth Kirschstein National Research Service Award
  • Adenoid Cystic Carcinoma Foundation Grant
  • HHMI-NIH Continuing Support Scholarship
  • American Association of Otolaryngology-Head and Neck Surgery
  • American Head and Neck Society
  • American Thyroid Association
  • AAOHNS Head and Neck Surgery and Oncology Committee

Show moreShow less

Click here for a list of peer-reviewed publications.

  • Marti JL, Avadhani V, Donatelli LA, Niyogi S, Wang B, Wong RJ, Shaha AR, Ghossein RA, Lin O, Morris LG, Ho AS. Wide inter-institutional variation in performance of a molecular classifier for indeterminate thyroid nodules. Ann of Surg Oncol. 2015. [Epub ahead of print]
  • Ho AS, Davies L, Nixon IJ, Palmer FL, Wang LY, Patel SG, Ganly I, Wong RJ, Tuttle RM, Morris LG. Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates. Cancer. 2015;121(11):1793-1799.
  • Ho AS, Sarti EE, Jain KS, Wang H, Nixon IJ, Shaha AR, Shah JP, Kraus DH, Ghossein R, Fish SA, et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid. 2014;24(5):832-839.
  • Ho AS1, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, et al. The mutational landscape of adenoid cystic carcinoma. Nat Genet. 2013;45(7):791-798.
  • Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG. Decision making in the management of recurrent head and neck cancer. Head Neck. 2014;36(1):144-151.
  • Ho AS, Tsao GJ, Chen FW, Shen T, Kaplan MJ, Colevas AD, Fischbein NJ, Quon A, Le QT, Pinto HA, et al. Impact of PET/CT surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013;119(7):1349-1356.

Show moreShow less

English / Chinese (Mandarin)

Make an Appointment




Available 24 Hours A Day


Send Email to Allen S. Ho, MD